logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available [see all tables in this series...]

Part (iii) Demographics of all men entering treatment

CountryYearMean age% Age <25% Age 35+
Bulgaria200625444
Czech Republic2006264710
Denmark2006332541
Germany2006293726
Ireland2006293617
Greece2006302621
Spain(1)2005322139
France2006303925
Italy(2)2006322238
Cyprus2006293519
Latvia(3)2006244712
Lithuania2006313723
Luxembourg2006322234
Hungary2006264614
Malta2006274714
Netherlands2006321946
Austria(4)2006274917
Poland(1)2005275118
Portugal(3)2006321939
Romania2006294117
Slovenia(5)200426498
Slovakia200625519
Finland2006283918
Sweden2006332740
United Kingdom(6)2006312730
Turkey2006303129

Notes:

 Data were not available for: Belgium, Estonia, Norway. 

 (1) Last data available refer to 2005. 

 (2) Until 2004, ‘all clients’ reported clients continuing in or entering treatment in reported year; since 2005 data are conformant with the TDI protocol. 

 (3) Data by gender refer to first treatments. 

 (4) Up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006, new data collection has been conducted. 

 (5) Last data available refer to 2004. It includes data for outpatient clients and clients treated in prison. Data for outpatient clients was validated, however data collection for prison clients was still in the process of development, thus figures are underestimated. With effect from next year the process of data validation for prison clients will be implemented.  

 (6) Data relate to the period from 1 April 2005 to 31 March 2006 for the UK. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Standard table 3. See Table TDI-1 for details on sources. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008